health

AIIMS Delhi performs a life-changing spinal repair in utero, before the patient’s first breath

AIIMS Delhi performs a life-changing spinal repair in utero, before the patient’s first breath

This is India’s first open foetal repair for myelomeningocele, a defect in which the spinal cord and its coverings protrude through an opening in the spine; over 30 clinicians and nurses involved in multidisciplinary procedure

Image used for representational purposes only.

The All India Institute of Medical Sciences (AIIMS), Delhi has performed India’s first open foetal repair of a lumbosacral myelomeningocele — the most severe form of spina bifida — at 25 weeks’ gestation.

“The six-hour operation repaired the cerebrospinal-fluid-leaking lumbosacral defect in utero. It followed more than five weeks of multidisciplinary planning, detailed foetal imaging, non-directive counselling, anaesthetic preparation, and operative simulation,’’ AIIMS said in a statement.

A myelomeningocele is an open neural tube defect in which the spinal cord and its coverings protrude through an opening in the spine.

The patient was first screened and counselled by K. Aparna Sharma from the Maternal–Fetal Medicine team. The multidisciplinary procedure was performed using high-end microscopy and continuous high-end ultrasonography assistance at the Neurosciences Centre. The procedure was provided free of cost to the family under the Union government’s Janani Shishu Suraksha Karyakram (JSSK).

Deepak Gupta, who led the neurosurgical component, said that the intervention was done after rigorous selection. “Prenatal repair seeks to limit ongoing injury to exposed neural tissue, reduce the subsequent need for cerebrospinal-fluid diversion for hydrocephalus, and improve selected neurological outcomes. It is not a cure, and long-term multidisciplinary care remains essential,” he said.

More than 30 clinicians and nurses from the Obstetrics and Gynaecology, Maternal–Fetal Medicine, Neurosurgery, Obstetrics and Neuroanaesthesia, Plastic Surgery, Radiodiagnosis, Neonatology, and Nursing teams of the Neurosciences Centre and Obstetrics–Gynaecology services participated in the procedure.

Professor Aparna Sharma added that this foetal intervention was well-reasoned and a planned decision aimed to optimise the outcomes of both the baby and the mother. The safety of both mother and foetus was ensured through detailed counselling, high-quality anaesthesia, and coordinated surveillance before and after surgery.

“International trial evidence supports prenatal repair in carefully selected foetuses with open myelomeningocele. The procedure nevertheless carries important maternal and foetal risks, including prematurity and uterine-scar complications, and must be performed only in specialised centres,’’ she said.

The team emphasised that foetal surgery is a treatment for selected pregnancies, not a substitute for prevention. Neural-tube closure occurs by approximately 28 days after conception, often before pregnancy is recognised. Pre-conception folic-acid counselling, evidence-based food fortification with folates, and robust national surveillance remain essential to reducing India’s burden of neural tube defects.

“The mother and foetus will continue to receive close multidisciplinary surveillance through pregnancy, delivery, and the newborn period,’’ the AIIMS statement said, adding that a child with spina bifida may begin life with paralysis, hydrocephalus, and lifelong challenges.

Traditionally, neurosurgeons have done this operation after the child is born. But by then, some of the neurological damage may already have occurred. For some children with spina bifida, the opportunity to protect the spinal cord now begins before birth.

  • repair
  • aiims
  • delhi
  • utero
  • patient
  • breath
  • life
  • india

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

Boots to begin prescribing medical cannabis in UK
health

Boots to begin prescribing medical cannabis in UK

Online service will be offered to patients with eligible conditions, in a first for a British high street pharmacy Boots is to start prescribing medical cannabis, it has announced, in a first for a UK high street pharmacy. The online service is being offered to patients in the UK aged 25 and older who have an eligible condition such as chronic pain, anxiety or insomnia.

Read →